BRUSSELS/LONDON (Reuters) -The relatively short shelf life of AstraZeneca Plc’s COVID-19 vaccine is complicating the rollout to the world’s poorest nations, according to officials and internal World Health Organization documents reviewed by Reuters. Read full story



